Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Visus Licenses Drugs From Cella, Delive
Device Transactions Medical device developers closed the third quarter of 2013 with $644 million in financing, a big decline compared with the previous two quarters, which each tallied both tallied ov
IN VITRO DIAGNOSTICS Mergers & Acquisitions Clinical Genomics Technologies Pty. Ltd. Quest Diagnostics Inc. Enterix Inc. As part of a continued effort to focus on its Diagnostics Information Services